Delivery Order SPE2DB22D3301-SPE2DB24FY1ZD
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,184.60 firm fixed-price delivery order covers the supply of EVEROLIMUS 5 MG TABLET UD 28S, with an ultimate completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,927.99 firm fixed-price contract is for the delivery of Everolimus 10 mg tablets, a medication used to treat certain medical conditions. The contract has an ultimate completion date of April 18, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,844.50 fixed-price delivery order contract is for the supply of EVEROLIMUS 0.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of July 10, 2025 and was awarded on July 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The company also holds a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $9,948.26, is for the delivery of Everolimus 1 mg tablets. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,856.17 to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order carries an ultimate completion date of August 12, 2025, with performance occurring at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,468.00 firm fixed price delivery order is for the supply of 4566165476 EVEROLIMUS 10 MG TABLET 30S, with a period of performance through October 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,788.61 firm fixed-price delivery order contract is for the supply of EVEROLIMUS 0.5 MG TABLET 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2022. It is not designated as a set-aside contract. Amerisourcebergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,073.21, is for the delivery of EVEROLIMUS 0.5 MG TABLET 60S, a prescription medication. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and has an ultimate completion date of April 8, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,972.74 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Everolimus 1 mg tablets (60 count). This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and represents a non-compete, competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of 4563469131 - Everolimus 0.75 mg Tablets in 60-count units, with a potential value of $1,605.00 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY1ZDDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EVEROLIMUS 5 MG TABLET UD 28S. The award has a potential value of $2,041.11 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for providing pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was issued under the IDC and does not have a set-aside designation.
Generated 6/5/24, 10:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/6/24 |